These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22429297)
1. Additive effects of clofibric acid and pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet. Hwang B; Wu P; Harris RA FEBS J; 2012 May; 279(10):1883-93. PubMed ID: 22429297 [TBL] [Abstract][Full Text] [Related]
2. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone. Holness MJ; Bulmer K; Smith ND; Sugden MC Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Holness MJ; Smith ND; Bulmer K; Hopkins T; Gibbons GF; Sugden MC Biochem J; 2002 Jun; 364(Pt 3):687-94. PubMed ID: 12049632 [TBL] [Abstract][Full Text] [Related]
4. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Jeoung NH; Harris RA Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E46-54. PubMed ID: 18430968 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor alpha (PPARalpha). Holness MJ; Bulmer K; Gibbons GF; Sugden MC Biochem J; 2002 Sep; 366(Pt 3):839-46. PubMed ID: 12099888 [TBL] [Abstract][Full Text] [Related]
6. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Wu P; Peters JM; Harris RA Biochem Biophys Res Commun; 2001 Sep; 287(2):391-6. PubMed ID: 11554740 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878 [TBL] [Abstract][Full Text] [Related]
8. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways. Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557 [TBL] [Abstract][Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
11. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice. Lin CH; Kuo YH; Shih CC Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085 [TBL] [Abstract][Full Text] [Related]
12. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
13. Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet. Hwang B; Jeoung NH; Harris RA Biochem J; 2009 Sep; 423(2):243-52. PubMed ID: 19627255 [TBL] [Abstract][Full Text] [Related]
14. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. Shiri-Sverdlov R; Wouters K; van Gorp PJ; Gijbels MJ; Noel B; Buffat L; Staels B; Maeda N; van Bilsen M; Hofker MH J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828 [TBL] [Abstract][Full Text] [Related]
15. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice. Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486 [TBL] [Abstract][Full Text] [Related]
16. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Huang B; Wu P; Bowker-Kinley MM; Harris RA Diabetes; 2002 Feb; 51(2):276-83. PubMed ID: 11812733 [TBL] [Abstract][Full Text] [Related]
17. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495 [TBL] [Abstract][Full Text] [Related]
18. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis. Zhang M; Zhao Y; Li Z; Wang C Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353 [TBL] [Abstract][Full Text] [Related]
19. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPARalpha in nonproliferating species. Cheon Y; Nara TY; Band MR; Beever JE; Wallig MA; Nakamura MT Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1525-35. PubMed ID: 15650118 [TBL] [Abstract][Full Text] [Related]
20. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease. Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109 [No Abstract] [Full Text] [Related] [Next] [New Search]